Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance
Daniel J. Fazakerley(University of Sydney), David E. James(The University of Sydney), Kyle L. Hoehn(UNSW Sydney), Roland Stocker(The Heart Research Institute), Daniel L. Chen(Toulouse School of Economics), Benjamin L. Parker(The University of Melbourne), Jean Yang(The University of Sydney), Christopher C. Meoli(The University of Sydney), Kelsey H. Fisher‐Wellman(Atrium Health Wake Forest Baptist), Warren Kaplan(Garvan Institute of Medical Research), Sean J. Humphrey(The University of Sydney), James G. Burchfield(The University of Sydney), Ciana Diskin(Trinity College), Ganesh Kolumam(Laboratoire d’Imagerie Biomédicale), Ghassan J. Maghzal(Victor Chang Cardiac Research Institute), Rima Chaudhuri(The University of Sydney), James R. Krycer(QIMR Berghofer Medical Research Institute), Dorit Samocha‐Bonet(Garvan Institute of Medical Research), Zora Modrušan(Unknown), Mark J. Cowley(Garvan Institute of Medical Research), Kristen C. Thomas(The University of Sydney), Jerry R. Greenfield(Garvan Institute of Medical Research), Pengyi Yang(The University of Sydney), Nolan J. Hoffman(Australian Catholic University)
Cited by 164
Related Papers
Regulated transport of the glucose transporter GLUT4
|Nature Reviews Molecular Cell Biology|2002|1.2k
Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States
|Diabetes|2006|1.1k
Molecular cloning and characterization of an insulin-regulatable glucose transporter
|Nature|1989|910
Clinical Relevance of Biomarkers of Oxidative Stress
|Antioxidants and Redox Signaling|2015|906